Abstract:To study the changes in T cell subsets and IL-7 in HIV-1-infected patients after seven years of highly active antiretroviral therapy (HAART). Seventy-five individuals were included in this study (25 with effective HAART, 18 with ineffective HAART, 17 untreated HIV+ patients, and 15 volunteers in the HIV negative control group). The counts of CD4+, CD8+, CD8/CD38+, and CD8/HLADR+ T cells as well as the IL-7 protein expression was measured at 5 time points during a period of seven years in patients starting HAART (baseline) and in the HIV negative control group. The expression of CD127 on CD3+ T cells was measured by flow cytometry at a single time point (after 7 years) in patients with HAART and was compared with untreated HIV+ patients and the HIV negative control group. At baseline CD4+ T cell counts of HIV-1-infected patients were lower than that in the control group (p < 0.01), whereas the CD8+, CD8/HLADR+ and CD8/CD38+ T cell counts were higher than those in the control group (p < 0.01). After seven years of effective HAART, the CD4+ T cell counts had increased and the CD8+ T cell count had decreased, although not to the normal levels (p < 0.05). Both the CD8/HLADR+ and CD8/CD38+ T cell counts had gradually approached those of the control group (p > 0.05). In the ineffective HAART group, the CD8/CD38+ T cell count had not decreased significantly, and CD8/HLADR+ T cell count gradually decreased. Before treatment, IL-7 serum levels of patients were significantly higher than that in the control group (p < 0.01). After seven years of effective HAART, IL-7 levels had gradually decreased, but were still higher than in the control group (p < 0.01). The CD127 expression on CD3+ CD8+ T cells in effective HAART patients was higher than in untreated HIV+ patients (p < 0.05), but was lower than that in the control group (p < 0.05). CD127 expression on CD3+ CD4+ T cells was not significantly different among the control group, untreated HIV+ patients and effective HAART group. After seven years of effective HAART, the quantity and capacity of T cell subsets and IL-7 in HIV-1-infected patients had been partially restored, and the abnormal immune activation has significantly diminished.

Progressive CD127 Down-Regulation Correlates with Increased Apoptosis of CD8 T Cells During Chronic HIV-1 Infection.

Expression of CD127 and its association with apoptosis of CD8 + T lymphocytes in patients with chronic HIV-1 infection

Study of T Cell Subsets and IL-7 Protein Expression in HIV-1-infected Patients after 7 Years HAART

Immune Activation and CD127 Expression on T Lymphocyte Subsets of a Chinese Cohort of Pediatric AIDS Patients with Different Viral Responses

Expression of CD127 of T lymphocytes in peripheral blood of patients with HIV-1/AIDS and its clinical significance

Microrna-155 is A Biomarker of T-Cell Activation and Immune Dysfunction in Hiv-1-Infected Patients

Inverse association of repressor growth factor independent-1 with CD8 T cell interleukin (IL)-7 receptor [alpha] expression and limited signal transducers and activators of transcription signaling in response to IL-7 among [gamma]-chain cytokines in HIV patients

Interleukin 7 Up-regulates CD95 Protein on CD4+ T Cells by Affecting mRNA Alternative Splicing: PRIMING FOR A SYNERGISTIC EFFECT ON HIV-1 RESERVOIR MAINTENANCE

HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Immunity Relation Between CD127 and HIV-1 Infection

B7-H1 Up-Regulation Impairs Myeloid Dc and Correlates with Disease Progression in Chronic Hiv-1 Infection

Impact of the CD4~+CD25~(nt/hi)CD127~(lo) Regulatory T Cells on the Immune Status and Disease Progression in HIV-1 Infected Individuals

HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

Preferential Apoptosis of HIV-1-Specific CD4+ T Cells

Dynamic Analysis of CD127 Expression on Memory CD8 T Cells from Patients with Chronic Hepatitis B During Telbivudine Treatment

FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity

HIV-1 Infection-Induced Suppression of the Let-7i/IL-2 Axis Contributes to CD4 + T Cell Death

HIV, Cytokines and Programmed Cell Death: A Subtle Interplay

Interleukin-21 Plays an Important Role in CD8 T-cell Activation and Poor Outcome in HIV Infection.

Caspase-1 Activity in CD4 T Cells Is Downregulated Following Antiretroviral Therapy for HIV-1 Infection